Ionis Pharmaceuticals, Inc.
Compositions for Modulating C9ORF72 Expression

Abstract:

Disclosed herein are compositions and methods for reducing expression of C9ORF72 mRNA and protein in an animal. Such methods are useful to treat, prevent, ameliorate, or slow progression of neurodegenerative diseases in an individual in need thereof.